Death and Destruction: How the Ubiquitin Proteasome System Executes Linker Cell-type Death
死亡与破坏:泛素蛋白酶体系统如何执行连接细胞型死亡
基本信息
- 批准号:10678636
- 负责人:
- 金额:$ 7.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-28 至 2024-09-27
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntibodiesApoptosisApoptoticBindingBiologicalCaenorhabditis elegansCaspaseCell DeathCell Death ProcessCell SurvivalCellsCessation of lifeCharacteristicsChromatinChromatin StructureCullin ProteinsDataDefectDevelopmentDiseaseElectron MicroscopyEmbryoEnzymesEpithelial CellsEtiologyExhibitsFemaleGenesGeneticGenetic EpistasisGenetic ScreeningGenetic TranscriptionGenetic studyGoalsHeat shock factorHeterochromatinHistonesHomeostasisHomologous GeneHuntington DiseaseHybridsLigaseLinkMaintenanceMalignant NeoplasmsMethodsMinorMolecularMorphologyMutationNerve DegenerationNeurodegenerative DisordersNeuronsNuclearPathway interactionsPatientsProcessProductionProteinsRNA interference screenResearchRoleS-AdenosylhomocysteineS-AdenosylmethionineSiteSpinalSpinal CordStainsStructureStructure of paramesonephric ductSystemTestingTimeTissuesTransferaseUBE2D2 geneUbiquitinUbiquitin-Conjugating EnzymesVertebral columnVertebratesYeastscell killingcell typechromatin remodelinghistone methylationhuman diseaseinnovationinsightlive cell imagingmalemethionine adenosyltransferasemulticatalytic endopeptidase complexmutantnew therapeutic targetnovelpolyglutamineprogramsprotein degradationreproductivetooltumorigenesisubiquitin-protein ligaseyeast two hybrid system
项目摘要
Project Summary
The long-term goal of the proposed research is to understand the cell biological mechanisms that
execute non-apoptotic cell death. Programmed cell death is essential for organismal development and
homeostasis, and its disruption is associated with many human diseases including cancer and
neurodegeneration. Apoptosis is a prominent cell death form, however mutations in key apoptotic regulators only
cause minor developmental defects. Non-apoptotic programs, therefore, also exist, but their molecular basis is
poorly understood. Linker Cell-type Death (LCD) is a non-apoptotic and caspase-independent cell death process
operating in C. elegans development, and its morphological hallmarks have also been observed in vertebrate
development and disease. The Ubiquitin Proteasome System (UPS) is a key effector of LCD in C. elegans, but
how it executes cell death is unknown. Here I will use powerful genetic and molecular tools in C. elegans
to identify and characterize the proteolytic targets of the UPS during LCD and determine how their
degradation trigger cell demise. In contrast to apoptosis, which uses caspases that transiently bind their
substrates and, remarkably, remain poorly understood, the UPS stably interacts with its substrates. Therefore,
the proteins I discover that precipitate cell death may unearth general mechanisms of cellular destruction that
also function during apoptosis and disease. Indeed, our preliminary data suggest that one candidate substrate
degraded by the UPS is an enzyme required for the maintenance of heterochromatin, which is in line with our
previous observations that dying linker cells exhibit an open chromatin state. Therefore, this proposal will
investigate the exciting hypothesis that chromatin remodeling, precipitated by the UPS, triggers cellular
destruction. I will also discover additional proteolytic targets and mechanisms that execute non-apoptotic cell
death with yeast 2-hybrid and RNAi screens. Because dysregulation of the UPS and chromatin state are also
linked to tumorigenesis and neurodegenerative diseases, my studies can provide greater understanding of cell
death programs disrupted in disease that can point towards new therapeutic targets.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lauren Bayer Horowitz其他文献
Lauren Bayer Horowitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lauren Bayer Horowitz', 18)}}的其他基金
Death and Destruction: How the Ubiquitin Proteasome System Executes Linker Cell-type Death
死亡与破坏:泛素蛋白酶体系统如何执行连接细胞型死亡
- 批准号:
10464485 - 财政年份:2022
- 资助金额:
$ 7.43万 - 项目类别:
Death and Destruction: How the Ubiquitin Proteasome System Executes Linker Cell-type Death
死亡与破坏:泛素蛋白酶体系统如何执行连接细胞型死亡
- 批准号:
10793327 - 财政年份:2022
- 资助金额:
$ 7.43万 - 项目类别:
Molecular mechanisms that regulate p38 MAPK-dependent neuronal gene expression
调节 p38 MAPK 依赖性神经元基因表达的分子机制
- 批准号:
9258109 - 财政年份:2016
- 资助金额:
$ 7.43万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 7.43万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 7.43万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 7.43万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 7.43万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别: